Epivaccorona
- All
- News
-
Russia's Second Vaccine "100% Effective" In Early-Stage Trials: Report
A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
-
Second Russian Virus Vaccine Passes Early Trials: Report
Early clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world's first vaccine.
-
Russia's Second Vaccine "100% Effective" In Early-Stage Trials: Report
A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
-
Second Russian Virus Vaccine Passes Early Trials: Report
Early clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world's first vaccine.
